Navigation Links
Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS

WASHINGTON, Nov. 9 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi released the following statement praising provisions in the Affordable Health Care for America Act (H.R. 3962) that will improve access to Medicaid and reduce Medicare Part D costs for people living with HIV/AIDS. H.R. 3962 passed the House on Saturday by a vote of 220 to 215:

"Effective drug treatments have improved both health and quality of life for thousands of Americans living with HIV/AIDS. However, many uninsured, low-income HIV-positive individuals still do not have access to these life-saving medications because they generally do not meet Medicaid requirements until becoming disabled by full-blown AIDS.

"Forcing people with HIV to wait for health care until their immune system is compromised by AIDS is bad health policy. The House health insurance reform bill dramatically increases access to Medicaid for all low-income Americans, including people living with HIV, by covering everyone up to 150 percent of the federal poverty level.

"For more than a decade, I have worked to expand access to Medicaid for people living with HIV through the Early Treatment for HIV Act. With Saturday's passage of the Affordable Health Care for America Act, the House has moved a step closer to not just achieving this goal, but exceeding it."


Currently, childless adults without a disability typically do not qualify for Medicaid at any income level. But even for parents and disabled adults eligibility is generally limited to those with incomes below 100 percent of the poverty level, and in many states the threshold is much lower.

The bill's expanded access to Medicaid begins in January 2013, when the new Health Insurance Exchange begins operation. In the interim, H.R. 3962 further ensures early access to care and treatment for people living with HIV by giving states the option of an enhanced federal match if they choose to cover people with HIV in their existing Medicaid programs. In participating states, people with HIV infection would qualify for coverage using the same eligibility standards that currently apply for disabled adults.

In addition, H.R. 3962 also finally allows medications provided through the AIDS Drug Assistance Program (ADAP) to count toward out-of-pocket costs in the Medicare Part D 'donut hole'. Prior to this change, ADAP beneficiaries would enter the "donut hole" coverage gap and then never leave it because their drug costs weren't being counted.

Now, ADAP beneficiaries will exit the "donut hole" more quickly, giving them access to the full range of medications covered under Medicare Part D. This is important because ADAP programs generally have a more limited formulary than the typical Medicare Part D plan.

SOURCE Office of the Speaker of the House

SOURCE Office of the Speaker of the House
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Pelosi Remarks at Press Conference Following Passage of the Affordable Health Care for America Act
2. Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention
3. Pelosi Remarks Following House Democrats Meeting with President Obama
4. Pelosi to House: Lets Destroy More Jobs
5. One Catholic Priest and Eleven Other Pro-Lifers Arrested for Tearing Up Nancy Pelosis Health Care Bill Outside Her Office; See Video Below
6. Statement from 60 Plus Association President Jim Martin on Speaker Nancy Pelosis New Health Care Proposal
7. Pelosi Remarks at Press Availability with Easter Seals on Benefits of Health Reform for Children
8. Pelosi Announces Key Provision in Health Insurance Reform for Young Adults
9. Pelosi: Senate Finance Committee Vote a Critical Step Toward Passage of Health Insurance Reform
10. Pelosi: Health Insurance Reform Essential for Women
11. Pelosi Congratulates UCSFs Elizabeth Blackburn for Receiving Nobel Prize in Medicine
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... A novel class ... could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the major ... showed that small molecule analogs that target the functions of SecA, a central ...
(Date:11/30/2015)... ... , ... Using a combination of two blood sugar tests rather than a ... a new study by researchers at the School of Public Health at Georgia State ... of Blood Glucose Tests ,” published in Frontiers in Public Health, the researchers noted ...
(Date:11/30/2015)... ... November 30, 2015 , ... International telepathology ... UPMC and KingMed Diagnostics researchers. Their review of more than ... with UPMC pathologists resulted in significantly altered treatment plans for more than half ...
(Date:11/30/2015)... ... November 30, 2015 , ... The Foundation for Breast and ... prevention—is joining forces with the award-winning creator and writer of Downton Abbey Julian ... 2015 at the Union League of Philadelphia. , The benefit, titled “An ...
(Date:11/30/2015)... ... November 30, 2015 , ... California-based i2i ... years, announced today that Michigan-based Family Health Center (FHC) has selected i2iTracks as ... years, FHC was awarded the largest Affordable Care Act grant for Federally Qualified ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Nov. 30, 2015 Booth #4303 – The Imaging ... will exhibit a broader array of products in a new ... of North America in ... meeting will feature X-ray components "At the Heart of Imaging." ... of products from Varian,s Claymount brand, and computer-aided diagnostic software ...
(Date:11/30/2015)... EAST HANOVER, N.J. , Nov. 30, 2015 /PRNewswire/ ... and portfolio at the 57 th American Society ... across leukemias, lymphomas and myelomas as well as supportive ... populations, in addition to personalized cell therapies. The ASH ... Orlando, Florida . Novartis Oncology ...
(Date:11/30/2015)... LONDON and BOSTON , ... to research and develop potential new medicines directed at ... multiple therapeutic areas. --> PFE ) to ... to 10 G protein-coupled receptor (GPCR) targets across multiple ... clinical-stage GPCR structure-guided drug discovery and development company and ...
Breaking Medicine Technology: